Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include Lexapro®(escitalopram oxalate) and Namenda®(memantine HCl).

Forest identifies, develops, and delivers pharmaceutical products that make a difference in people's lives. We have been extremely successful in meeting our business objectives and expanding our franchises, but we also derive satisfaction in helping to bring relief to people who are suffering. We credit our success to our innovation, integrity, and commitment to developing important products.

A unique approach to product development

To provide innovative and effective medicines, we rely on a strategy that is straightforward and successful:

  • License promising new products from innovative companies worldwide at virtually every stage of development
  • Conduct rigorous scientific investigation and development of drug therapies that make a unique contribution to the field of healthcare and the lives of patients
  • Execute superior marketing and sales initiatives to firmly establish our products in the marketplace

Built on integrity

Forest proudly and actively promotes professional behavior and personal integrity in every aspect of our business operations. We believe that the highest ethical behavior is consistent with our ambition to deliver therapies that will favorably impact the health and well-being of patients.

Our standards have earned Forest a place on the Forbes Platinum list of the 400 best companies in America for each of the past three years, with special recognition as the best managed company in the Drug and Biotechnology industry in 2004.

What's ahead for Forest?

At Forest, we believe in the power of potential—the potential of science, purpose, and people. As a nimble pharmaceutical company, we are dedicated to concentrating our energies and using our experience to bring important treatments to the marketplace.

We are proud of our success and excited by our potential. We anticipate continued, steady growth in our product pipeline, revenues, and workforce. Learn more about Forest by exploring our products, investor relations, and careers.

FOREST AT-A-GLANCE

  • CEO:
    Howard Solomon
  • Corporate Headquarters:
    New York, New York
  • Year Founded:
    1954 (incorporated 1956)
  • Employees (global):
    5,000
  • Sales Force:
    2,800
  • FY 2008 Revenues:
    $3,836 (US$ mil.)
  • Stock Exchange Listing:

    New York Stock Exchange (FRX)
  • Website:

    www.frx.com